Inspiration Biopharmaceuticals announced that it has submitted a Biologics License Application (BLA) to the FDA for the approval of IB1001 for the treatment and prevention of bleeding in individuals with hemophilia B.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.